Simponi 50 mg/0.5 mL single-dose prefilled syringe Images
Generic Name: golimumab
This medication has been identified as Simponi 50 mg/0.5 mL single-dose prefilled syringe. It is supplied by Janssen Biotech, Inc.
Simponi is used in the treatment of Ankylosing Spondylitis; Rheumatoid Arthritis; Psoriatic Arthritis; Spondyloarthritis; Ulcerative Colitis and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Simponi 50 mg/0.5 mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Simponi
- Generic Name
- golimumab
- Strength
- 50 mg/0.5 mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Biotech, Inc.
- National Drug Code (NDC)
- 57894-0070
More about Simponi (golimumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (110)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.